Načítá se...
BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema
INTRODUCTION: Brain swelling due to edema formation is a major cause of neurological deterioration and death in patients with large hemispheric infarction (LHI) and severe traumatic brain injury (TBI), especially contusion-TBI. Preclinical studies have shown that SUR1-TRPM4 channels play a critical...
Uloženo v:
| Vydáno v: | Expert Opin Investig Drugs |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6893098/ https://ncbi.nlm.nih.gov/pubmed/31623469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2019.1681967 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|